REGENXBIO Inc. RGNX 35.83
Health Care · NASDAQ · Data as of 2026-08-06
REGENXBIO Inc. (RGNX) has delivered +33.2% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1652 of 1968 stocks overall and #207 of 260 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
35.83
Overall Rank
#1652 / 1968
Sector Rank
#207 / 260
Revenue CAGR
+33.2%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio